Sjöholm Malin I L, Hoffmann Gunilla, Lindgren Stefan, Dillner Joakim, Carlson Joyce
Department of Clinical Chemistry, University Hospital MAS, Entrance 71, 205-02 Malmö, Sweden.
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):251-5.
Biobanks containing formalin-fixed paraffin-embedded tissue, as well as frozen serum or plasma, are important resources for molecular epidemiologic studies. However, few studies have compared the reliability of formalin-fixed tissue samples and archival plasma samples for genotyping. We determined the genotype of four proposed genetic risk factors for hepatocellular carcinoma [hereditary hemochromatosis (HFE 63 and 282), alpha(1)-antitrypsin deficiency (AAT 342) and cystic fibrosis (CFTR 508)] on formalin-fixed tissue samples, stored for up to 25 years, from 318 patients diagnosed with hepatocellular carcinoma and on plasma or serum samples from 31 of these patients. The genotypes were analyzed by RFLP or allele-specific amplification as well as by TaqMan assays. In addition, genotyping was attempted after whole genome amplification by multiple displacement amplification (MDA). Genotyping was successful in 94% of the tissue samples and successful and identical to the tissue samples from the same subjects in 98% of the plasma/serum samples. DNA from plasma samples could be amplified >5,000-fold by MDA and genotyping after MDA gave identical results to the genotyping of the same subjects before whole genome amplification. MDA amplification of the tissue samples was not successful. In summary, archival plasma was found to be an adequate source of efficiently amplifiable DNA. MDA on plasma samples allows analysis of multiple genotypes in epidemiologic studies.
包含福尔马林固定石蜡包埋组织以及冷冻血清或血浆的生物样本库是分子流行病学研究的重要资源。然而,很少有研究比较福尔马林固定组织样本和存档血浆样本进行基因分型的可靠性。我们对318例肝细胞癌患者福尔马林固定长达25年的组织样本以及其中31例患者的血浆或血清样本,测定了肝细胞癌四个拟议的遗传风险因素的基因型[遗传性血色素沉着症(HFE 63和282)、α1抗胰蛋白酶缺乏症(AAT 342)和囊性纤维化(CFTR 508)]。通过限制性片段长度多态性分析(RFLP)或等位基因特异性扩增以及TaqMan分析对基因型进行分析。此外,在通过多重置换扩增(MDA)进行全基因组扩增后尝试进行基因分型。94%的组织样本基因分型成功,98%的血浆/血清样本基因分型成功且与同一受试者的组织样本一致。血浆样本中的DNA可通过MDA扩增>5000倍,MDA后基因分型与全基因组扩增前同一受试者的基因分型结果相同。组织样本的MDA扩增未成功。总之,发现存档血浆是高效可扩增DNA的充足来源。血浆样本的MDA可用于在流行病学研究中分析多种基因型。